When will the FDA approve Compass Pathways' COMP360 Psilocybin?
This market resolves based on the date the FDA approves Compass Pathways' COMP360 Psilocybin.
Kalshi$12 traded 24hEnds Dec 31, 2026Outcomes
Yes pays $1 if it happens · best price highlighted
| Outcome | Chance | 24h | Last 24h | Kalshi |
|---|---|---|---|---|
| Before Jan 1, 2027 | 36% | — | 39¢ | |
| Before 2028 | 89% | — | 92¢ | |
| Before October 2027 | 87% | — | 90¢ | |
| Before July 2027 | 82% | — | 84¢ | |
| Before Mar 1, 2027 | 64% | — | 66¢ |
Before Jan 1, 2027
36%
—Yes price on Kalshi, last 2 weeks
Discussion
Posts and calls about this event
Live room
Connecting…Loading…
Sign in to chat in the room.